• A C.D.C. panel recommends J.&J. shots restart with a label noting the risk of very rare blood clots

    13 days ago - By New York Times

    The U.S. government is likely to follow the panel's recommendation and end the pause.
    Read more ...


  • CDC advisory panel backs J&J's Covid-19 vaccine, clearing way for pause to be lifted

    13 days ago - By STAT

    An expert panel on Friday recommended that the United States resume use of Johnson & Johnson's Covid-19 vaccine, likely ending a 10-day “pause” placed on the vaccine after a small number of unusual clotting events were reported among people who had received it.
    The Food and Drug Administration and the Centers for Disease Control and Prevention, which had jointly issued the pause, were expected to lift it Friday evening, on the advice of the Advisory Committee on Immunization Practices.
    Read more ...


  • A new study hints at a reason the J.&J. and AstraZeneca vaccines may cause blood clots in rare cases

    14 days ago - By New York Times

    A panel of experts advising the Centers for Disease Control and Prevention is discussing rare blood clots that health officials have investigated in Johnson & Johnson coronavirus vaccine recipients.
    Read more ...